Schroder Investment Management Group’s AdaptHealth AHCO Stock Holding History

Schroder Investment Management Group’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-471,010	Closed	-$7.96M	–	1308
2022 Q1	$7.96M	Sell	471,010 -9,864	-2%	-$177K	0.01%	724
2021 Q4	$11.8M	Sell	480,874 -8,440	-2%	-$198K	0.02%	583
2021 Q3	$11.4M	Sell	489,314 -28,567	-6%	-$691K	0.02%	603
2021 Q2	$14.2M	Sell	517,881 -170,047	-25%	-$4.85M	0.02%	592
2021 Q1	$25.3M	Buy	687,928 +190,907	+38%	+$6.74M	0.03%	446
2020 Q4	$18.7M	Buy	497,021 +79,685	+19%	+$2.47M	0.03%	500
2020 Q3	$9.77M	Buy	+417,336	New	+$8.76M	0.02%	593

Other funds holding AHCO

OCA

OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Schroder Investment Management Group's AHCO Position: Q2 2022 in Review

Schroder Investment Management Group sold out of AdaptHealth (AHCO) in Q2 2022, closing a stake of 471,010 shares — an estimated $7.96M sold.

Schroder Investment Management Group first reported a position in AHCO in Q3 2020 and held it in 7 quarters. The position peaked at $25.3M in Q1 2021. 149 funds tracked by Wall St. Rank hold AHCO as of Q2 2022.

Schroder Investment Management Group reported no remaining AdaptHealth position as of Q2 2022 after selling out during the quarter.
Schroder Investment Management Group sold 471,010 AdaptHealth shares in Q2 2022, an estimated $7.96M.
Schroder Investment Management Group first reported a position in AdaptHealth in Q3 2020 and held it in 7 quarters.
Schroder Investment Management Group's AdaptHealth position peaked at $25.3M in Q1 2021.
149 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2022.

Based on Schroder Investment Management Group's 13F filing for Q2 2022, filed 11 Aug 2022.